Pharmacokinetics and Pharmacodynamics of Biological Drugs
Course, Master's level, 3FB037
Expand the information below to show details on how to apply and entry requirements.
Autumn 2026 Autumn 2026, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 2 December 2026–17 January 2027
- Language of instruction
- English
- Entry requirements
-
150 credits which of 120 credits in biomedicine, biology, pharmaceutical science, chemistry and/or science/engineering. Prior studies should contain 5 credits in pharmacokinetics and 7.5 credits in pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
- Du som inte är medborgare i ett EU-/EES-land eller Schweiz måste i regel betala anmälnings- och studieavgift.
- First tuition fee instalment: SEK 20,625
- Total tuition fee: SEK 20,625
- Application deadline
- 15 April 2026
- Application code
- UU-39205
Admitted or on the waiting list?
- Registration period
- 25 November 2026–2 December 2026
- Information on registration from the department
About the course
The course provides a detailed picture of how different biological medicines are distributed and eliminated and how different target structures and disease states can affect their dose-concentration-effect relationship. Through lectures and workshops, the course sheds light on how the relationships affect both drug development and use, in comparison with more traditional drugs.
The course focuses on protein medicines and antibodies but also covers other types of biological medicines such as peptides, oligonucleotides, vaccines and cell therapies. We also discuss how knowledge about the dose-response relationships of biological medicines in preclinical studies is used to define clinical study design.
Reading list
No reading list found.